Quantitative Characterization of Partitioning Stringency in SELEX

28 March 2024, Version 2
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Maintaining stringent conditions in SELEX (Systematic Evolution of Ligands by EXponential enrichment) is crucial for obtaining high-affinity aptamers; however, excessive stringency greatly increases the risk of SELEX failure. The control of stringency remains a technical challenge reliant solely on intuition, largely due to the absence of a measure of stringency. Essentially, researchers increase or decrease stringency through its influencers without defining and quantitating it. This study was motivated by our insight that while stringency may not be easily definable via its multiple influencers, it can be delineated by its effect: increasing stringency leads to a decrease in the normalized quantity of binders at the output of partitioning. Building on this insight, we introduce a measure of stringency called the Binder-to-Nonbinder Ratio (BNR) and derive an expression for its experimental determination using a single experimental tool: quantitative PCR. The outcomes of our theoretical analysis and the result of SELEX experiments targeting three distinct protein targets underscore the importance of maintaining a BNR significantly greater than zero to avoid SELEX failure due to excessive stringency – a principle that we term the SELEX non-failure criterion. Utilizing BNR as a measure of stringency alongside this criterion will enable researchers to rationally control SELEX progress.

Keywords

SELEX
Risk assessment in SELEX
Measure of stringency in SELEX
Binder-to-nonbinder ratio at the output of partitioning
Statistical criterion for highest stringency

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.